Capsule for hepatitis B

Abstract

The invention provides a hepatitis B capsule, the weight portions of each ingredient of the raw material formula of which is as follows: 20 portions of portulaca grandiflora, 10 portions of herba oldenlandiae, 10 portions of Indian damnacanthus herb, 2 portions of radix gentiana, 5 portions of lucid ganoderma, 10 portions of alpinia japonica (Thunb.) Miq., 10 portions of rhizome atractylodis alba, 20 portions of semen cassiae, 10 portions of root of Chinese thorowax, 5 portions of buah keras and 5 portions of anoectochilus formosanus. Preparation steps of the invention are as follows: crude drugs are weighed according to raw material ratio and then are ground into powder which is mixed evenly, thus obtaining the hepatitis B capsule through packing the powder. The hepatitis B capsule of the invention adopts natural rare green herbage as raw material which is matched scientifically and reasonably and has simple preparation technique and no additives are added during the preparation process; the hepatitis B capsule prepared by the invention can cure hepatitis B with obvious efficacy, almost has no toxicity and side effect, and can be taken for a long time.

Description

technical field [0001] The invention belongs to the field of medicine, and more specifically relates to a hepatitis B capsule. Background technique [0002] Hepatitis B, also known as serum hepatitis and viral hepatitis B (referred to as hepatitis B), is an infectious disease caused by hepatitis B virus (HBV). Transmitted through blood and body fluids, with a chronic carrier state. The disease is widely prevalent in my country, and the infection rate among the population is high, and the infection rate reaches more than 35% in some areas. According to relevant data, the number of patients who tested positive for hepatitis has reached 189 million, while the number of people who should see a doctor but have not (carriers) is nearly 400 million. It is the most serious infectious disease currently endangering people's health. More common in children and young adults. The clinical manifestations of hepatitis B are diverse, and it is easy to develop into chronic hepatitis and ...

AI Technical Summary

Problems solved by technology

At present, antiviral drugs such as 1a-interferon, immunomodulators, and lamivudine are mostly used in the treatment of hepatitis B, which have large toxic and side effects and are harmful to human health if taken for a long time. However, general Chinese medicine preparations have little effect and have little therapeutic effect on hepatitis B.